𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon

✍ Scribed by Régis Pouillot; Guillaume Lachenal; Oliver G. Pybus; Dominique Rousset; Richard Njouom

Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
777 KB
Volume
8
Category
Article
ISSN
1567-1348

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence for high genetic diversity and
Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa
✍ Jeannel, Dominique; Fretz, Catherine; Traore, Yves; Kohdjo, Nicolas; Bigot, Andr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

During 1994 and 1995, the prevalence of hepatitis C virus (HCV) and its genotypes were studied in several rural and urban populations in three West African countries: Guinea, Burkina Faso, and Benin. The following groups were screened for antibodies to HCV (anti-HCV): 459 villagers in the forest reg

Hepatitis B and C infections, human immu
Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa
✍ Patrice Combe; Guy La Ruche; Dominique Bonard; Timothée Ouassa; Hortense Faye-Ke 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 570 KB

Few studies have been conducted in developing countries to estimate the prevalence of hepatitis C virus (HCV) infection and its association with human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs). We have screened for hepatitis B virus (HBV) and HCV markers 200 HIV-1 -

Effects of interferon treatment on the a
Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients
✍ G Missale; E Cariani; V Lamonaca; A Ravaggi; A Rossini; R Bertoni; M Houghton; Y 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 3 views

The viral genotype may influence the response to interferon sion and more efficient antiviral immune response, is still (IFN) treatment in chronic hepatitis C virus (HCV) infection. unclear. To characterize potential mechanisms responsible for this ef-Several factors including viral load, disease se

Randomized comparison of 12 or 24 weeks
Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
✍ Martin Lagging; Nina Langeland; Court Pedersen; Martti Färkkilä; Mads Rauning Bu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

Previous trials investigating the efficacy of treatment durations shorter than the standard of 24 weeks for chronic hepatitis C virus (HCV) genotype 2/3 infections have yielded discordant results. The aims of this investigator-initiated phase III study were to compare the efficacy of 12 or 24 weeks